Leap Therapeutics Inc Cash Flow-to-Debt Ratio
Leap Therapeutics Inc cash flow-to-debt ratio. Leap Therapeutics Inc (LPTX) has a Cash Flow-to-Debt Ratio of -1.87x as of September 2025, meaning its operating cash flow of $-16.29 Million could theoretically repay -2% of its total liabilities ($8.70 Million) in one year. Check earnings quality score of Leap Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Leap Therapeutics Inc (2012–2024)
Cash flow-to-debt ratio of Leap Therapeutics Inc from 2012 to 2024. Historical debt coverage capacity for Leap Therapeutics Inc across 13 annual periods. Check LPTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Leap Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
Leap Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Leap Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Leap Therapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.28x | $-60.30 Million | $14.08 Million | ▼ -24.2% |
| 2023 | -3.45x | $-43.75 Million | $12.68 Million | ▲ +75.7% |
| 2022 | -14.22x | $-49.04 Million | $3.45 Million | ▼ -305.4% |
| 2021 | -3.51x | $-35.16 Million | $10.02 Million | ▲ +59.3% |
| 2020 | -8.62x | $-25.96 Million | $3.01 Million | ▼ -194.8% |
| 2019 | -2.93x | $-26.90 Million | $9.20 Million | ▼ -11.2% |
| 2018 | -2.63x | $-26.03 Million | $9.90 Million | ▼ -113.2% |
| 2017 | -1.23x | $-22.14 Million | $17.95 Million | ▲ +68.6% |
| 2016 | -3.92x | $-25.34 Million | $6.46 Million | ▲ +74.4% |
| 2015 | -15.31x | $-19.58 Million | $1.28 Million | ▼ -111.4% |
| 2014 | -7.24x | $-18.02 Million | $2.49 Million | ▼ -43.6% |
| 2013 | -5.04x | $-9.94 Million | $1.97 Million | ▼ -208.1% |
| 2012 | -1.64x | $-7.55 Million | $4.61 Million | — |